Luke Petersen, a Swiss banker, faces up to his bank's structural, cyclical and market problems in health investment. This case scrutinises the infrastructure of technology transfer, the implementation of recent projects across different organisations and strategic considerations for the role of technology transfer in the future of European health investment. It provides an up-to-date study of a successful investment fund in the rapidly changing life sciences sector. The study will benefit stakeholders interested in technology transfer, private equity, and innovation management. The case also informs the debate on broader societal issues related to technology transfer, in particular the tension between commercial interests and the public good.
- Managing technology transfer organizations - Valuation of intellectual property - Managing risk across various development stages - Selecting seed stage venture investments - Stakeholder communications